DrJoan Ni Gabhann-Dromgoole
Senior Lecturer
School of Pharmacy and Biomolecular Sciences
Orcid identifier0000-0002-4247-3952 (opens in a new tab)
- Senior LecturerSchool of Pharmacy and Biomolecular Sciences
- 01 4025216 (Work)
- RCSI, Molecular & Cellular Therapeutics, 123 St Stephens Green, Dublin 2
RESEARCH OVERVIEW
Our research program is targeting the underlying pathology the autoimmune disease Sjogren’s Syndrome (SS), which gives rise to dry eyes and dry mouth through reduced exocrine gland function, as well as contributing to a range of extra glandular complications. These complications can range in severity from fatigue to the development of pulmonary fibrosis, interstitial lung disease and in certain cases, non-Hodgkin’s lymphoma. There are no effective therapies for SS or diagnostic tests that allow identification of patients who will go on to develop further complications. Our work aims to address this need through targeting the molecular mechanisms that underpin SS development and pathogenesis. Recently our research has focussed on investigating the role of non-coding microRNAs that regulate inflammation, and in particular pathogenic cytokine production, to the pathogenesis of SS. Given the critically important role of inflammation and dysregulated inflammatory cytokine production in a variety of autoimmune conditions and dry eye diseases our research also aims to delineate a role for these novel regulatory molecules in inflammatory diseases with the hope of identifying new therapeutic targets and diagnostics.
Our group successfully operates within a clinician-scientist framework, thus we are uniquely positioned within RCSI and the Royal Victoria Eye and Ear Hospital to investigate the immunological component to a range of ocular surface diseases. The clinical lead in our group, Prof Conor Murphy, Professor of Ophthalmology, has established research interests in the areas of uveitis, herpes simplex keratitis and dry eye disease (DED). We currently focus on DED particularly in the context of the autoimmune condition, SS. However, the underlying inflammatory or immune component across the presentations of DED means that our research will be applicable to a range of conditions including age related dry eye disease, aqueous tear deficiency and potentially graft versus host disease in the context of corneal transplantation.
Our group successfully operates within a clinician-scientist framework, thus we are uniquely positioned within RCSI and the Royal Victoria Eye and Ear Hospital to investigate the immunological component to a range of ocular surface diseases. The clinical lead in our group, Prof Conor Murphy, Professor of Ophthalmology, has established research interests in the areas of uveitis, herpes simplex keratitis and dry eye disease (DED). We currently focus on DED particularly in the context of the autoimmune condition, SS. However, the underlying inflammatory or immune component across the presentations of DED means that our research will be applicable to a range of conditions including age related dry eye disease, aqueous tear deficiency and potentially graft versus host disease in the context of corneal transplantation.
GRANTS
- FUNDED PROJECTBScATT 2026 PlacementsRCSI29 Jun 2026 - 31 Dec 2026
- FUNDED PROJECTStAR International PhD Programme 2023RCSI1 Sep 2023 - 31 Aug 2027
- FUNDED PROJECTConference Support FundsIndustry10 May 2023 - 9 May 2028
- FUNDED PROJECTProfiling emerging immune signatures associated with developing inflammatory ocular graft versus host disease and adverse outcomes from corneal transplantation (PREDICT).Enterprise Ireland8 Sep 2022 - 7 Sep 2023
- FUNDED PROJECTMultiomic characterization of ocular graft versus host disease from patient tearsRoyal Victoria Eye & Ear Hospital Research Foundation1 Oct 2021 - 30 Sep 2022
- FUNDED PROJECTCollaborate Initiative – IPORCSI1 Sep 2021 - 31 Dec 2024
- FUNDED PROJECTNational PPI Network AwardHealth Research Board / HRB1 Mar 2021 - 28 Feb 2026People funded by this grant:
- Sean D,
- Ruth M,
- Martin O,
- Patricia K,
- Veronica L
- FUNDED PROJECTEstablishing a two dimensional and three-dimensional model of inflammatory dry eye disease to test novel therapeutics using primary human conjunctival epithelial cellsRoyal Victoria Eye & Ear Hospital Research Foundation16 Nov 2020 - 31 Jul 2022
- FUNDED PROJECTMultiomic profiling of ocular inflammation in dry eye disease relating to ocular graft versus host diseaseRoyal Victoria Eye & Ear Hospital Research Foundation20 Feb 2020 - 31 Mar 2022
- FUNDED PROJECTSSC Research Programme 2020RCSI1 Jan 2020 - 31 Mar 2021
- FUNDED PROJECTEstablishing a 2D and three-dimensional model of inflammatory dry eye disease to test novel therapeutics using primary human conjunctival epithelial cells’Irish College of Opthalmologists - ICO1 Jul 2019 - 31 Jul 2022
- FUNDED PROJECTRCSI Research Summer School 2019RCSI12 Apr 2019 - 31 Jan 2022
- FUNDED PROJECTTargeting ocular inflammation in dry eye disease with novel microRNA-based therapeuticsRoyal Victoria Eye & Ear Hospital Research Foundation1 Nov 2018 - 31 Mar 2022
- FUNDED PROJECTTargeting dry eye disease (DED) and ocular graft-versus-host disease (GVHD) with novel microRNA-based therapeuticsIrish College of Opthalmologists - ICO16 Oct 2018 - 16 Oct 2022
- FUNDED PROJECTModulating microRNA expression as a means to restore immune function in patients with primary Sjogrens SyndromeRCSI1 Jan 2015 - 31 Dec 2015
- FUNDED PROJECTTargeting inflammation in the autoimmune condtions Sjögren’s syndrome and systemic lupus erythematosus –novel microRNAs as potential therapeuticsTrinity College Dublin24 Mar 2014 - 30 Jun 2014